Haley Echlin

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Topics

Multidrug Resistant

Reactive Oxygen Species

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Tina H Dao, Haley Echlin, Abigail McKnight, Enolia S Marr, Julia Junker, Qidong Jia, Randall T Hayden, Tim van Opijnen, Ralph R Isberg, Vaughn S Cooper, Jason W Rosch
Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones. mBio (2024)
Tina H Dao, Haley Echlin, Abigail McKnight, Enolia S Marr, Julia Junker, Qidong Jia, Randall T Hayden, Tim van Opijnen, Ralph R Isberg, Vaughn S Cooper, Jason W Rosch
Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones. mBio 15 (2) (2024)
Tina H Dao, Haley Echlin, Abigail McKnight, Enolia S Marr, Julia Junker, Qidong Jia, Randall T Hayden, Tim van Opijnen, Ralph R Isberg, Vaughn S Cooper, Jason W Rosch
Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones. mBio 15 (2) (2024)
Tina H Dao, Haley Echlin, Abigail McKnight, Enolia S Marr, Julia Junker, Qidong Jia, Randall T Hayden, Tim van Opijnen, Ralph R Isberg, Vaughn S Cooper, Jason W Rosch
Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones. mBio 15 (2) (2024)
Tina H Dao, Haley Echlin, Abigail McKnight, Enolia S Marr, Julia Junker, Qidong Jia, Randall T Hayden, Tim van Opijnen, Ralph R Isberg, Vaughn S Cooper, Jason W Rosch
Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones. mBio (2024)